TY  - JOUR
AU  - Cabello-Ubeda, Alfonso
AU  - Baeza, Alicia Gonzalez
AU  - Garcia, Jesus Troya
AU  - de La Fuente Moral, Sara
AU  - Mena, Maria Novella
AU  - Martinez, Adriana Pinto
AU  - Mican, Rafael
AU  - Gorgolas, Miguel
AU  - Tascon, Guillermo Cuevas
AU  - de Santiago, Alberto Diaz
AU  - Morerno, Jose Sanz
AU  - Crestelo, David Rial
AU  - Arenzana, Carmen Busca
AU  - Serna, Jose Ignacio Bernardino
AU  - Almiron, Mariana Diaz
AU  - Cano, Joanna
AU  - Esteban, Herminia
AU  - Perez-Valero, Ignacio
PY  - 2022
DO  - 10.1093/ofid/ofac345
SN  - 2328-8957
UR  - http://hdl.handle.net/10668/19825
T2  - Open forum infectious diseases
AB  - Although switching antiretroviral therapy (ART) in people with human immunodeficiency virus experiencing insomnia due to dolutegravir-related neurotoxicity is well founded upon evidence, there is a lack of proof in regard to the outcome of stopping...
LA  - en
PB  - Oxford University Press
KW  - CNS
KW  - Clinical trial
KW  - Darunavir
KW  - Dolutegravir
KW  - Neurotoxicity
KW  - Lamivudine
KW  - Darunavir
KW  - HIV
KW  - Sleep initiation and maintenance disorders
KW  - Depression
KW  - Sleep quality
KW  - HIV infections
TI  - Changes in Quality of Sleep, Mood, and Other Neuropsychiatric Symptoms After Switching Dolutegravir/Lamivudine/Abacavir to Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Randomized Study of People With Human Immunodeficiency Virus With Poor Sleep Quality: GESIDA 10418.
TY  - research article
VL  - 9
ER  -